Literature DB >> 19451623

The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection.

Ilona Hauber1, Heinrich Hohenberg, Barbara Holstermann, Werner Hunstein, Joachim Hauber.   

Abstract

Peptide fragments, derived from prostatic acidic phosphatase, are secreted in large amounts into human semen and form amyloid fibrils. These fibrillar structures, termed semen-derived enhancer of virus infection (SEVI), capture HIV virions and direct them to target cells. Thus, SEVI appears to be an important infectivity factor of HIV during sexual transmission. Here, we are able to demonstrate that epigallocatechin-3-gallate (EGCG), the major active constituent of green tea, targets SEVI for degradation. Furthermore, it is shown that EGCG inhibits SEVI activity and abrogates semen-mediated enhancement of HIV-1 infection in the absence of cellular toxicity. Therefore, EGCG appears to be a promising supplement to antiretroviral microbicides to reduce sexual transmission of HIV-1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451623      PMCID: PMC2683882          DOI: 10.1073/pnas.0811827106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  Amyloid fibrillogenesis: themes and variations.

Authors:  J C Rochet; P T Lansbury
Journal:  Curr Opin Struct Biol       Date:  2000-02       Impact factor: 6.809

Review 2.  Is green tea good for HIV-1 infection?

Authors:  Christina L Nance; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

Review 3.  Inhibition of carcinogenesis by tea.

Authors:  Chung S Yang; Pius Maliakal; Xiaofeng Meng
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

4.  Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent.

Authors:  Gianfranco Fassina; Anna Buffa; Roberto Benelli; Oliviero E Varnier; Douglas M Noonan; Adriana Albini
Journal:  AIDS       Date:  2002-04-12       Impact factor: 4.177

5.  Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1).

Authors:  Koushi Yamaguchi; Mitsuo Honda; Hajime Ikigai; Yukihiko Hara; Tadakatsu Shimamura
Journal:  Antiviral Res       Date:  2002-01       Impact factor: 5.970

6.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 7.  Therapeutic strategies for human amyloid diseases.

Authors:  James C Sacchettini; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

8.  EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers.

Authors:  Dagmar E Ehrnhoefer; Jan Bieschke; Annett Boeddrich; Martin Herbst; Laura Masino; Rudi Lurz; Sabine Engemann; Annalisa Pastore; Erich E Wanker
Journal:  Nat Struct Mol Biol       Date:  2008-05-30       Impact factor: 15.369

9.  Whither or wither microbicides?

Authors:  Robert M Grant; Dean Hamer; Thomas Hope; Rowena Johnston; Joep Lange; Michael M Lederman; Judy Lieberman; Christopher J Miller; John P Moore; Donald E Mosier; Douglas D Richman; Robert T Schooley; Marty S Springer; Ronald S Veazey; Mark A Wainberg
Journal:  Science       Date:  2008-07-25       Impact factor: 47.728

Review 10.  Toxic proteins in neurodegenerative disease.

Authors:  J Paul Taylor; John Hardy; Kenneth H Fischbeck
Journal:  Science       Date:  2002-06-14       Impact factor: 47.728

View more
  63 in total

1.  Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides.

Authors:  Onofrio Zirafi; Kyeong-Ae Kim; Nadia R Roan; Silvia F Kluge; Janis A Müller; Shibo Jiang; Benjamin Mayer; Warner C Greene; Frank Kirchhoff; Jan Münch
Journal:  Sci Transl Med       Date:  2014-11-12       Impact factor: 17.956

2.  Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols.

Authors:  Ping Cao; Daniel P Raleigh
Journal:  Biochemistry       Date:  2012-03-21       Impact factor: 3.162

3.  Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection.

Authors:  Franziska Arnold; Jacqueline Schnell; Onofrio Zirafi; Christina Stürzel; Christoph Meier; Tanja Weil; Ludger Ständker; Wolf-Georg Forssmann; Nadia R Roan; Warner C Greene; Frank Kirchhoff; Jan Münch
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

Review 4.  Emergence and natural selection of drug-resistant prions.

Authors:  James Shorter
Journal:  Mol Biosyst       Date:  2010-04-27

5.  The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency.

Authors:  Jeffrey R Brender; Ravi Prakash Reddy Nanga; Nataliya Popovych; Ronald Soong; Peter M Macdonald; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2011-01-22

6.  Morphology-Dependent HIV-Enhancing Effect of Semen-Derived Enhancer of Viral Infection.

Authors:  Xin Qiao; Jaekyun Jeon; Amy L Cole; Jason O Matos; Stephany Bautista; Justin Castillo; Ivan Hung; Zhehong Gan; Suren A Tatulian; Alexander M Cole; Bo Chen
Journal:  Biophys J       Date:  2015-04-21       Impact factor: 4.033

7.  ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.

Authors:  Tianrong Xun; Wenjuan Li; Jinquan Chen; Fei Yu; Wei Xu; Qian Wang; Ruizhe Yu; Xiaojuan Li; Xuefeng Zhou; Lu Lu; Shibo Jiang; Lin Li; Suiyi Tan; Shuwen Liu
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

8.  Inhibition of semen-derived enhancer of virus infection (SEVI) fibrillogenesis by zinc and copper.

Authors:  Sarah R Sheftic; Jessica M Snell; Suman Jha; Andrei T Alexandrescu
Journal:  Eur Biophys J       Date:  2012-08-21       Impact factor: 1.733

9.  A molecular tweezer antagonizes seminal amyloids and HIV infection.

Authors:  Edina Lump; Laura M Castellano; Christoph Meier; Janine Seeliger; Nelli Erwin; Benjamin Sperlich; Christina M Stürzel; Shariq Usmani; Rebecca M Hammond; Jens von Einem; Gisa Gerold; Florian Kreppel; Kenny Bravo-Rodriguez; Thomas Pietschmann; Veronica M Holmes; David Palesch; Onofrio Zirafi; Drew Weissman; Andrea Sowislok; Burkhard Wettig; Christian Heid; Frank Kirchhoff; Tanja Weil; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan; Elsa Sanchez-Garcia; Roland Winter; James Shorter; Jan Münch
Journal:  Elife       Date:  2015-08-18       Impact factor: 8.140

10.  Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.

Authors:  Kyeong-Ae Kim; Maral Yolamanova; Onofrio Zirafi; Nadia R Roan; Ludger Staendker; Wolf-Georg Forssmann; Adam Burgener; Nathalie Dejucq-Rainsford; Beatrice H Hahn; George M Shaw; Warner C Greene; Frank Kirchhoff; Jan Münch
Journal:  Retrovirology       Date:  2010-06-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.